Location: Home
  • search
  • go
  • Relate News
  • 11/11/2022NMPA Announces Package Insert Revision of Phloroglucinol Injection
  • 11/4/2022NMPA Announces Package Insert Revision of Methotrexate Oral Formulatio...
  • 11/2/2022NMPA Announces Package Insert Revision of Liver Hydrolyzed Peptide Inj...
  • 11/1/2022China Bars Celebrities from Endorsing Products to Boost 'Traditional V...
  • 10/31/2022Big Pharma Dominated the Deals Space in September (PharmaDJ)
  • 10/27/2022NMPA Announces Package Insert Revision of Domperidone Formulations
  • 10/18/2022Financing for China Drugmakers Hits the Lowest of the Year (PharmaDJ)
  • 10/14/2022Singapore Is Becoming a Hotspot for Chinese Drugmakers Looking to Go P...
  • 10/9/2022CDE Solicits Comments on Draft Opinions for Reform and Improvement of ...
  • 9/29/2022More MNCs Are Partnering with Chinese Drugmakers in Licensing Deals (P...
  • 9/21/2022China Approved Its First Homegrown CD20 Antibody in August (PharmaDJ)
  • 9/16/2022Chinese Pharma Companies Raised Over $500M in August (PharmaDJ)
  • 9/15/2022CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...
  • 8/22/2022Drug R&D and Approvals in China – July Update on YouTube (PharmCube)
  • 8/18/2022Kidney Disease Drugs A Hot Spot for July In-licensing (PharmaDJ)
  • 8/17/2022Gilead to Acquire Remaining Worldwide Rights of Trodelvy from Everest ...
  • 8/17/2022Huadong Completes Acquisition of 35% Stake in Heidelberg Pharma
  • 8/15/2022BeiGene Enters Strategic Alliance with Ontada to Improve U.S. Communit...
  • 8/9/2022Ophthalmology A New Opportunity for Biotechs in China (PharmaDJ)
  • 8/2/2022China Slaps MAH System on Vaccine Manufacturing to Limit Newcomers (Ph...
  • 7/28/2022June In-Licensing Deals in China Biotech Drop to A New Low (PharmaDJ)
  • 7/28/2022Elevation Oncology and CSPC Pharma Enter Licensing Deal for Latter's A...
  • 7/26/2022Biotech fundraising in China Warms Up A Little in June (PharmaDJ)
  • 7/26/2022Mobile Health Applications for Depression in China: A Systematic Revie...
  • 7/14/2022Chinese Biopharma In-licensing Deals in H1/2022 (Pharmcube)
  • 7/14/2022China's Budding Drug Innovation Shows Signs of Life Despite Biotech Wi...
  • 7/13/2022Chinese Drugmakers Set Sights on Emerging Markets (PharmaDJ)
  • 7/5/2022Biotech Winter in China Set to Adjust Valuation and Prompt Consolidati...
  • 7/1/2022PharmaDJ: MSD and Turning Point Turn to China for Big Deals in May
  • 6/28/2022CDE Solicits Comments on the Draft Technical Guidelines for Clinical E...
  • Page:5/25 Total number of articles:748: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group